Inhibition of GSK3β ameliorated renal injury by ameliorating tubular cell apoptosis and injury, indicating the potential value of GSK3β in blocking the progression of AKI and the subsequent transformation to CKD [185]. This evidence concerns the gene GSK3B and chronic kidney disease.